Probing the pharmacology of G protein-coupled receptors with fluorescent ligands

Neuropharmacology

Volumn 98, Issue , 2015, Pages 48-57

  Stoddart, Leigh A ^a   Kilpatrick, Laura E ^a   Briddon, Stephen J ^a   Hill, Stephen J ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

Confocal microscopy; Fluorescence correlation spectroscopy; Fluorescent ligands; GPCR

Indexed keywords

4 (3 TERT BUTYLAMINO 2 HYDROXYPROPOXY) 2 BENZIMIDAZOLONE; ABA BY 630; ABEA BY 630; ADENOSINE A1 RECEPTOR AGONIST; ADENOSINE A1 RECEPTOR ANTAGONIST; ADENOSINE A3 RECEPTOR ANTAGONIST; ADENOSINE RECEPTOR BLOCKING AGENT; ADENOSINE RECEPTOR STIMULATING AGENT; AF 532; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CA 200645; FLUORESCENT LIGAND; G PROTEIN COUPLED RECEPTOR; GALANIN; LIGAND; MEMBRANE RECEPTOR; MEPYRAMINE; NEW DRUG; NORADRENALIN; RHODAMINE; UNCLASSIFIED DRUG; X BY 630; XAC BY 630; FLUORESCENT DYE;

CONFOCAL MICROSCOPY; DRUG RECEPTOR BINDING; DRUG TARGETING; FLUORESCENCE; HUMAN; IMAGING; MEMBRANE; NONHUMAN; PHYSIOLOGICAL PROCESS; PRIORITY JOURNAL; REVIEW; ANIMAL; CHEMISTRY; METABOLISM; RADIOASSAY;

ANIMALS; FLUORESCENT DYES; HUMANS; LIGANDS; RADIOLIGAND ASSAY; RECEPTORS, G-PROTEIN-COUPLED;

EID: 84947032597     PISSN: 00283908     EISSN: 18737064     Source Type: Journal    
DOI: 10.1016/j.neuropharm.2015.04.033     Document Type: Review

References (87)

1. L. Albizu, M. Cottet, M. Kralikova, S. Stoev, R. Seyer, I. Brabet, and et al. Time-resolved FRET between GPCR ligands reveals oligomers in native tissues Nat. Chem. Biol. 6 8 2010 587 594
2. M. Allen, J. Reeves, and G. Mellor High throughput fluorescence polarization: a homogeneous alternative to radioligand binding for cell surface receptors J. Biomol. Screen 5 2 2000 63 69
3. S. Arttamangkul, V. Alvarez-Maubecin, G. Thomas, J.T. Williams, and D.K. Grandy Binding and internalization of fluorescent opioid peptide conjugates in living cells Mol. Pharmacol. 58 6 2000 1570 1580
4. S. Arttamangkul, M. Torrecilla, K. Kobayashi, H. Okano, and J.T. Williams Separation of mu-opioid receptor desensitization and internalization: endogenous receptors in primary neuronal cultures J. Neurosci. 26 15 2006 4118 4125
5. J.G. Baker, L.A. Adams, K. Salchow, S.N. Mistry, R.J. Middleton, S.J. Hill, and et al. Synthesis and characterization of high-affinity 4, 4-Difluoro-4-bora-3a,4a-diaza-s-indacene-labeled fluorescent ligands for human beta-adrenoceptors J. Med. Chem. 54 19 2011 6874 6887
6. J.G. Baker, I.P. Hall, and S.J. Hill Agonist actions of "beta-blockers" provide evidence for two agonist activation sites or conformations of the human beta1-adrenoceptor Mol. Pharmacol. 63 6 2003 1312 1321
7. J.G. Baker, R. Middleton, L. Adams, L.T. May, S.J. Briddon, B. Kellam, and et al. Influence of fluorophore and linker composition on the pharmacology of fluorescent adenosine A(1) receptor ligands Br. J. Pharmacol. 159 4 2010 772 786
8. J. Bockaert, and J.P. Pin Molecular tinkering of G protein-coupled receptors: an evolutionary success EMBO J. 18 7 1999 1723 1729
9. F. Brand, A.M. Klutz, K.A. Jacobson, B.B. Fredholm, and G. Schulte Adenosine A(2A) receptor dynamics studied with the novel fluorescent agonist Alexa488-APEC Eur. J. Pharmacol. 590 1-3 2008 36 42
10. S.J. Briddon, and S.J. Hill Pharmacology under the microscope: the use of fluorescence correlation spectroscopy to determine the properties of ligand-receptor complexes Trends Pharmacol. Sci. 28 12 2007 637 645
11. S.J. Briddon, B. Kellam, and S.J. Hill Design and use of fluorescent ligands to study ligand-receptor interactions in single living cells Methods Mol. Biol. 746 2011 211 236
12. S.J. Briddon, R.J. Middleton, Y. Cordeaux, F.M. Flavin, J.A. Weinstein, M.W. George, and et al. Quantitative analysis of the formation and diffusion of A1-adenosine receptor-antagonist complexes in single living cells Proc. Natl. Acad. Sci. U. S. A. 101 13 2004 4673 4678
13. S.J. Briddon, R.J. Middleton, A.S. Yates, M.W. George, B. Kellam, and S.J. Hill Application of fluorescence correlation spectroscopy to the measurement of agonist binding to a G-protein coupled receptor at the single cell level Faraday Discuss. 126 2004 197 207
14. D. Calebiro, V.O. Nikolaev, L. Persani, and M.J. Lohse Signaling by internalized G-protein-coupled receptors Trends Pharmacol. Sci. 31 5 2010 221 228
15. D. Calebiro, F. Rieken, J. Wagner, T. Sungkaworn, U. Zabel, A. Borzi, and et al. Single-molecule analysis of fluorescently labeled G-protein-coupled receptors reveals complexes with distinct dynamics and organization Proc. Natl. Acad. Sci. U. S. A 110 2 2013 743 748
16. M. Castro, V.O. Nikolaev, D. Palm, M.J. Lohse, and J.-P. Vilardaga Turn-on switch in parathyroid hormone receptor by a two-step parathyroid hormone binding mechanism Proc. Natl. Acad. Sci. U. S. A. 102 44 2005 16084 16089
17. S. Chen, M.J. Webber, J.P. Vilardaga, A. Khatri, D. Brown, D.A. Ausiello, and et al. Visualizing microtubule-dependent vasopressin type 2 receptor trafficking using a new high-affinity fluorescent vasopressin ligand Endocrinology 152 10 2011 3893 3904
18. M. Corbani, M. Trueba, S. Stoev, B. Murat, J. Mion, V. Boulay, and et al. Design, synthesis, and pharmacological characterization of fluorescent peptides for imaging human V1b vasopressin or oxytocin receptors J. Med. Chem. 54 8 2011 2864 2877
19. Y. Cordeaux, S.J. Briddon, S.P. Alexander, B. Kellam, and S.J. Hill Agonist-occupied A3 adenosine receptors exist within heterogeneous complexes in membrane microdomains of individual living cells FASEB J. 22 3 2008 850 860
20. R. Corriden, L.E. Kilpatrick, B. Kellam, S.J. Briddon, and S.J. Hill Kinetic analysis of antagonist-occupied adenosine-A3 receptors within membrane microdomains of individual cells provides evidence of receptor dimerization and allosterism FASEB J. 28 10 2014 4211 4222
21. R. Corriden, T. Self, K. Akong-Moore, V. Nizet, B. Kellam, S.J. Briddon, and et al. Adenosine-A3 receptors in neutrophil microdomains promote the formation of bacteria-tethering cytonemes EMBO Rep. 14 8 2013 726 732
22. M. Cottet, O. Faklaris, D. Maurel, P. Scholler, E. Doumazane, E. Trinquet, and et al. BRET and time-resolved FRET strategy to study GPCR oligomerization: from cell lines toward native tissues Front. Endocrinol. (Lausanne) 3 2012 92
23. M. Cottet, O. Faklaris, J.M. Zwier, E. Trinquet, J.-P. Pin, and T. Durroux Original fluorescent ligand-based assays open new perspectives in G-protein coupled receptor drug screening Pharmaceuticals 4 1 2011 202 214
24. C.J. Daly, R.A. Ross, J. Whyte, C.M. Henstridge, A.J. Irving, and J.C. McGrath Fluorescent ligand binding reveals heterogeneous distribution of adrenoceptors and 'cannabinoid-like' receptors in small arteries Br. J. Pharmacol. 159 4 2010 787 796
25. F. Daumas, N. Destainville, C. Millot, A. Lopez, D. Dean, and L. Salome Confined diffusion without fences of a g-protein-coupled receptor as revealed by single particle tracking Biophys. J. 84 1 2003 356 366
26. S. Diekmann, and C. Hoischen Biomolecular dynamics and binding studies in the living cell Phys. Life Rev. 11 1 2014 1 30
27. K.N. Fish Total internal reflection fluorescence (TIRF) microscopy Curr. Protoc. Cytom. 50 2009 12.18.1 12.18.13
28. S.L. Garland Are GPCRs still a source of new targets? J. Biomol. Screen 18 9 2013 947 966
29. K. Gherbi, S.J. Briddon, and S.J. Hill Detection of the secondary, low-affinity beta1 -adrenoceptor site in living cells using the fluorescent CGP 12177 derivative BODIPY-TMR-CGP Br. J. Pharmacol. 171 23 2014 5431 5445
30. M. Grant, R.C. Patel, and U. Kumar The role of subtype-specific ligand binding and the C-tail domain in dimer formation of human somatostatin receptors J. Biol. Chem. 279 37 2004 38636 38643
31. J. Guo, L. Song, M. Liu, and M.J. Mahon Fluorescent ligand-directed co-localization of the parathyroid hormone 1 receptor with the brush-border scaffold complex of the proximal tubule reveals hormone-dependent changes in ezrin immunoreactivity consistent with inactivation Biochim. Biophys. Acta 1823 12 2012 2243 2253
32. K.G. Harikumar, K. Hosohata, D.I. Pinon, and L.J. Miller Use of probes with fluorescence indicator distributed throughout the pharmacophore to examine the peptide agonist-binding environment of the family B G protein-coupled secretin receptor J. Biol. Chem. 281 5 2006 2543 2550
33. S. Hatse, K. Princen, S. Liekens, K. Vermeire, E. De Clercq, and D. Schols Fluorescent CXCL12AF647 as a novel probe for nonradioactive CXCL12/CXCR4 cellular interaction studies Cytometry 61 2 2004 178 188
34. H.T. He, and D. Marguet Detecting nanodomains in living cell membrane by fluorescence correlation spectroscopy Annu. Rev. Phys. Chem. 62 2011 417 436
35. O. Hegener, L. Prenner, F. Runkel, S.L. Baader, J. Kappler, and H. Haberlein Dynamics of beta2-adrenergic receptor-ligand complexes on living cells Biochemistry 43 20 2004 6190 6199
36. J.A. Hern, A.H. Baig, G.I. Mashanov, B. Birdsall, J.E. Corrie, S. Lazareno, and et al. Formation and dissociation of M1 muscarinic receptor dimers seen by total internal reflection fluorescence imaging of single molecules Proc. Natl. Acad. Sci. U. S. A. 107 6 2010 2693 2698
37. K. Herrick-Davis, E. Grinde, A. Cowan, and J.E. Mazurkiewicz Fluorescence correlation spectroscopy analysis of serotonin, adrenergic, muscarinic, and dopamine receptor dimerization: the oligomer number puzzle Mol. Pharmacol. 84 4 2013 630 642
38. A.L. Hopkins, C.R. Groom, and A. Alex Ligand efficiency: a useful metric for lead selection Drug Discov. Today 9 10 2004 430 431
39. R.A. Houghten, C.T. Dooley, and J.R. Appel De novo identification of highly active fluorescent kappa opioid ligands from a rhodamine labeled tetrapeptide positional scanning library Bioorg. Med. Chem. Lett. 14 8 2004 1947 1951
40. C. Hounsou, J.F. Margathe, N. Oueslati, A. Belhocine, E. Dupuis, C. Thomas, and et al. Time-resolved FRET binding assay to investigate hetero-oligomer binding properties: proof of concept with dopamine D/D heterodimer ACS Chem. Biol. 10 2 2014 466 474
41. L. Hunyady, A.J. Baukal, Z. Gaborik, J.A. Olivares-Reyes, M. Bor, M. Szaszak, and et al. Differential PI 3-kinase dependence of early and late phases of recycling of the internalized AT1 angiotensin receptor J. Cell. Biol. 157 7 2002 1211 1222
42. P.A. Insel, B.P. Head, H.H. Patel, D.M. Roth, R.A. Bundey, and J.S. Swaney Compartmentation of G-protein-coupled receptors and their signalling components in lipid rafts and caveolae Biochem. Soc. Trans. 33 Pt 5 2005 1131 1134
43. R. Irannejad, J.C. Tomshine, J.R. Tomshine, M. Chevalier, J.P. Mahoney, J. Steyaert, and et al. Conformational biosensors reveal GPCR signalling from endosomes Nature 495 7442 2013 534 538
44. R. Irannejad, and M. von Zastrow GPCR signaling along the endocytic pathway Curr. Opin. Cell. Biol. 27 2014 109 116
45. X. Iturrioz, R. Alvear-Perez, N. De Mota, C. Franchet, F. Guillier, V. Leroux, and et al. Identification and pharmacological properties of E339-3D6, the first nonpeptidic apelin receptor agonist FASEB J. 24 5 2010 1506 1517
46. K.C. Jonas, F. Fanelli, I.T. Huhtaniemi, and A.C. Hanyaloglu Single molecule analysis of functionally asymmetric GPCR oligomers reveals diverse spatial and structural assemblies J. Biol. Chem. 290 7 2014 3875 3892
47. R.S. Kasai, and A. Kusumi Single-molecule imaging revealed dynamic GPCR dimerization Curr. Opin. Cell. Biol. 27 2014 78 86
48. R.S. Kasai, K.G. Suzuki, E.R. Prossnitz, I. Koyama-Honda, C. Nakada, T.K. Fujiwara, and et al. Full characterization of GPCR monomer-dimer dynamic equilibrium by single molecule imaging J. Cell. Biol. 192 3 2011 463 480
49. L.E. Kilpatrick, S.J. Briddon, and N.D. Holliday Fluorescence correlation spectroscopy, combined with bimolecular fluorescence complementation, reveals the effects of beta-arrestin complexes and endocytic targeting on the membrane mobility of neuropeptide Y receptors Biochim. Biophys. acta 1823 6 2012 1068 1081
50. A.A. Konkar, Z. Zhu, and J.G. Granneman Aryloxypropanolamine and catecholamine ligand interactions with the beta(1)-adrenergic receptor: evidence for interaction with distinct conformations of beta(1)-adrenergic receptors J. Pharmcol. Exp. Ther. 294 3 2000 923 932
51. A.J. Kooistra, R. Leurs, I.J. de Esch, and C. de Graaf From three-dimensional GPCR structure to rational ligand discovery Adv. Exp. Med. Biol. 796 2014 129 157
52. E. Kozma, P.S. Jayasekara, L. Squarcialupi, S. Paoletta, S. Moro, S. Federico, and et al. Fluorescent ligands for adenosine receptors Bioorg. Med. Chem. Lett. 23 1 2013 26 36
53. K.J. Kuder, and K. Kiec-Kononowicz Fluorescent GPCR ligands as new tools in pharmacology-update, years 2008-early 2014 Curr. Med. Chem. 21 34 2014 3962 3975
54. J.P. Leyris, T. Roux, E. Trinquet, P. Verdie, J.A. Fehrentz, N. Oueslati, and et al. Homogeneous time-resolved fluorescence-based assay to screen for ligands targeting the growth hormone secretagogue receptor type 1a Anal. Biochem. 408 2 2011 253 262
55. S. Loison, M. Cottet, H. Orcel, H. Adihou, R. Rahmeh, L. Lamarque, and et al. Selective fluorescent nonpeptidic antagonists for vasopressin V(2) GPCR: application to ligand screening and oligomerization assays J. Med. Chem. 55 20 2012 8588 8602
56. D. Maurel, L. Comps-Agrar, C. Brock, M.L. Rives, E. Bourrier, M.A. Ayoub, and et al. Cell-surface protein-protein interaction analysis with time-resolved FRET and snap-tag technologies: application to GPCR oligomerization Nat. Methods 5 6 2008 561 567
57. L.T. May, L.J. Bridge, L.A. Stoddart, S.J. Briddon, and S.J. Hill Allosteric interactions across native adenosine-A(3) receptor homodimers: quantification using single-cell ligand-binding kinetics FASEB J. 25 10 2011 3465 3476
58. L.T. May, T.J. Self, S.J. Briddon, and S.J. Hill The effect of allosteric modulators on the kinetics of agonist-G protein-coupled receptor interactions in single living cells Mol. Pharmacol. 78 3 2010 511 523
59. L. Methven, M. McBride, G.A. Wallace, and J.C. McGrath The alpha 1B/D-adrenoceptor knockout mouse permits isolation of the vascular alpha 1A-adrenoceptor and elucidates its relationship to the other subtypes Br. J. Pharmacol. 158 1 2009 209 224
60. L. Methven, P.C. Simpson, and J.C. McGrath Alpha1A/B-knockout mice explain the native alpha1D-adrenoceptor's role in vasoconstriction and show that its location is independent of the other alpha1-subtypes Br. J. Pharmacol. 158 7 2009 1663 1675
61. R.J. Middleton, S.J. Briddon, Y. Cordeaux, A.S. Yates, C.L. Dale, M.W. George, and et al. New fluorescent adenosine A1-receptor agonists that allow quantification of ligand-receptor interactions in microdomains of single living cells J. Med. Chem. 50 4 2007 782 793
62. S. Morishima, F. Suzuki, A. Nishimune, H. Yoshiki, H. Akino, O. Yokoyama, and et al. Visualization and tissue distribution of alpha1L-adrenoceptor in human prostate by the fluorescently labeled ligand Alexa-488-silodosin J. Urol. 183 2 2010 812 819
63. J.D. Muller, Y. Chen, and E. Gratton Resolving heterogeneity on the single molecular level with the photon-counting histogram Biophys. J. 78 1 2000 474 486
64. C.L. Padgett, and P.A. Slesinger GABAB receptor coupling to G-proteins and ion channels Adv. Pharmacol. 58 2010 123 147
65. R.R. Petrov, M.E. Ferrini, Z. Jaffar, C.M. Thompson, K. Roberts, and P. Diaz Design and evaluation of a novel fluorescent CB2 ligand as probe for receptor visualization in immune cells Bioorg. Med. Chem. Lett. 21 19 2011 5859 5862
66. A. Pramanik, M. Olsson, U. Langel, T. Bartfai, and R. Rigler Fluorescence correlation spectroscopy detects galanin receptor diversity on insulinoma cells Biochemistry 40 36 2001 10839 10845
67. L. Prenner, A. Sieben, K. Zeller, D. Weiser, and H. Haberlein Reduction of high-affinity beta2-adrenergic receptor binding by hyperforin and hyperoside on rat C6 glioblastoma cells measured by fluorescence correlation spectroscopy Biochemistry 46 17 2007 5106 5113
68. J. Ries, and P. Schwille Fluorescence correlation spectroscopy Bioessays 34 5 2012 361 368
69. R.H. Rose, S.J. Briddon, and S.J. Hill A novel fluorescent histamine H(1) receptor antagonist demonstrates the advantage of using fluorescence correlation spectroscopy to study the binding of lipophilic ligands Br. J. Pharmacol. 165 6 2012 1789 1800
70. A. Sabirsh, A. Wetterholm, J. Bristulf, H. Leffler, J.Z. Haeggstrom, and C. Owman Fluorescent leukotriene B4: potential applications J. Lipid Res. 46 6 2005 1339 1346
71. F. Schiele, P. Ayaz, and A. Fernandez-Montalvan A universal homogeneous assay for high-throughput determination of binding kinetics Anal. Biochem. 468C 2014 42 49
72. E. Schneider, M. Keller, A. Brennauer, B.K. Hoefelschweiger, D. Gross, O.S. Wolfbeis, and et al. Synthesis and characterization of the first fluorescent nonpeptide NPY Y1 receptor antagonist Chembiochem 8 16 2007 1981 1988
73. R. Seifert Functional selectivity of G-protein-coupled receptors: from recombinant systems to native human cells Biochem. Pharmacol. 86 7 2013 853 861
74. R. Sridharan, J. Zuber, S.M. Connelly, E. Mathew, and M.E. Dumont Fluorescent approaches for understanding interactions of ligands with G protein coupled receptors Biochim. Biophys. Acta 1838 1 Pt A 2014 15 33
75. L.A. Stoddart, A.J. Vernall, J.L. Denman, S.J. Briddon, B. Kellam, and S.J. Hill Fragment screening at adenosine-A(3) receptors in living cells using a fluorescence-based binding assay Chem. Biol. 19 9 2012 1105 1115
76. 3 receptor and localization with arrestin3 using a fluorescent agonist Neuropharmacol 98 2015 68 77 10.1016/j.neuropharm.2015.04.013
77. K. Suzuki, K. Ritchie, E. Kajikawa, T. Fujiwara, and A. Kusumi Rapid hop diffusion of a G-protein-coupled receptor in the plasma membrane as revealed by single-molecule techniques Biophys. J. 88 5 2005 3659 3680
78. M. Tomasch, J.S. Schwed, K. Kuczka, S. Meyer Dos Santos, S. Harder, R.M. Nusing, and et al. Fluorescent human EP3 receptor antagonists ACS Med. Chem. Lett. 3 9 2012 774 779
79. M. Tomasch, J.S. Schwed, A. Paulke, and H. Stark Bodilisant-a novel fluorescent, highly affine histamine h3 receptor ligand ACS Med. Chem. Lett. 4 2 2012 269 273
80. G. Vauquelin, and S.J. Charlton Long-lasting target binding and rebinding as mechanisms to prolong in vivo drug action Br. J. Pharmacol. 161 3 2010 488 508
81. S. Veiksina, S. Kopanchuk, and A. Rinken Budded baculoviruses as a tool for a homogeneous fluorescence anisotropy-based assay of ligand binding to G protein-coupled receptors: the case of melanocortin 4 receptors Biochim. Biophys. Acta 1838 1 Pt B 2014 372 381
82. A.J. Vernall, S.J. Hill, and B. Kellam The evolving small-molecule fluorescent-conjugate toolbox for Class A GPCRs Br. J. Pharmacol. 171 5 2014 1073 1084
83. A.J. Vernall, L.A. Stoddart, S.J. Briddon, S.J. Hill, and B. Kellam Highly potent and selective fluorescent antaognists of the human adenosine A3 receptor based on the 1,2,4-triazolol[4,3-a]quinoxalin-1-one scaffold J. Med. Chem. 55 4 2012 1771 1782
84. A.J. Vernall, L.A. Stoddart, S.J. Briddon, H.W. Ng, C.A. Laughton, S.W. Doughty, and et al. Conversion of a non-selective adenosine receptor antagonist into A3-selective high affinity fluorescent probes using peptide-based linkers Org. Biomol. Chem. 11 34 2013 5673 5682
85. S.M. Young, C. Bologa, E.R. Prossnitz, T.I. Oprea, L.A. Sklar, and B.S. Edwards High-throughput screening with HyperCyt (R) flow cytometry to detect small molecule formylpeptide receptor ligands J. Biomol. Screen 10 4 2005 374 382
86. R. Ziemek, A. Brennauer, E. Schneider, C. Cabrele, A.G. Beck-Sickinger, G. Bernhardt, and et al. Fluorescence- and luminescence-based methods for the determination of affinity and activity of neuropeptide Y2 receptor ligands Eur. J. Pharmacol. 551 1-3 2006 10 18
87. J.M. Zwier, T. Roux, M. Cottet, T. Durroux, S. Douzon, S. Bdioui, and et al. A fluorescent ligand-binding alternative using tag-lite (R) technology J. Biomol. Screen 15 10 2010 1248 1259